Ophthalmic Ultrasound Devices

Ophthalmic Ultrasound Devices Market Outlook

The global ophthalmic ultrasound devices market was valued at approximately USD 1.2 billion in 2023 and is projected to reach USD 2.2 billion by 2035, with a compound annual growth rate (CAGR) of around 7.0% during the forecast period of 2025-2035. The increasing prevalence of eye diseases such as cataracts, glaucoma, and diabetic retinopathy, alongside the growing elderly population, is a significant driver of market growth. Technological advancements leading to the development of innovative ultrasound devices that offer better precision and ease of use further contribute to the uptick in demand. Additionally, the rising emphasis on early diagnosis and preventive healthcare in ophthalmology is propelling the market forward, as healthcare providers increasingly adopt advanced diagnostic tools to improve patient outcomes. The ongoing research and development initiatives to enhance imaging modalities and the integration of artificial intelligence in ultrasound systems are expected to create a favorable environment for growth in the ophthalmic ultrasound devices market.

Growth Factor of the Market

The growth of the ophthalmic ultrasound devices market is significantly influenced by various factors that enhance patient care and diagnostic accuracy. One of the primary factors is the escalating incidence of ocular disorders, which necessitate the use of advanced imaging techniques for accurate diagnosis and management. Additionally, the increased awareness about eye health and the importance of regular eye examinations have led to a rise in healthcare visits, further boosting the demand for ophthalmic ultrasound devices. Furthermore, the advancements in technology, such as the development of portable and user-friendly ultrasound devices, have made these tools more accessible to healthcare providers, thereby facilitating their adoption in various clinical settings. The growing investment in healthcare infrastructure, particularly in emerging markets, is also expected to contribute to the market's development. Moreover, the integration of telemedicine and remote diagnostics due to the recent global health crises has created new opportunities for ophthalmic ultrasound devices, allowing patients to receive timely care even from a distance.

Key Highlights of the Market

• The global ophthalmic ultrasound devices market is projected to experience a CAGR of 7.0% from 2025 to 2035.
• Technological advancements are driving the development of next-generation ultrasound devices.
• Increased prevalence of ocular diseases is a significant factor for market growth.
• Portable ultrasound devices are gaining traction due to their convenience and ease of use.
• Emerging markets are expected to witness substantial growth due to improving healthcare infrastructure.

By Product Type

A-scan Ultrasound:

A-scan ultrasound devices are widely used in ophthalmology for measuring the axial length of the eye, which is crucial for intraocular lens (IOL) calculations prior to cataract surgery. They provide a one-dimensional view of the eye, helping clinicians assess the size of the eye structure accurately. The simplicity of A-scan ultrasound devices makes them a common choice in outpatient settings, contributing to their popularity. As the demand for cataract surgery rises, so too does the need for A-scan devices, further driving market growth. The efficiency and reliability of A-scan ultrasound in determining eye measurements are essential for achieving optimal surgical outcomes, thus propelling their use in clinical practice.

B-scan Ultrasound:

B-scan ultrasound devices produce two-dimensional cross-sectional images of the eye and surrounding tissues, enabling a comprehensive assessment of various ocular diseases. They are particularly useful for visualizing the retina and vitreous in cases where direct observation is challenging, such as with opaque media. B-scan ultrasound is instrumental in diagnosing conditions like retinal detachment, tumors, and other abnormalities. Its ability to provide detailed imagery enhances the diagnostic capabilities of ophthalmologists, making it an indispensable tool in clinical practice. The growing incidence of retinal disorders is driving demand for B-scan devices, as timely and accurate imaging plays a critical role in effective treatment planning.

Combined A/B-scan Ultrasound:

Combined A/B-scan ultrasound devices offer the advantages of both A-scan and B-scan technologies, providing a comprehensive imaging solution for ophthalmologists. This versatility allows for precise axial length measurements while simultaneously enabling detailed visualization of ocular structures. The ability to switch between A-scan and B-scan modes enhances diagnostic accuracy, making these devices highly sought after in both surgical and clinical settings. As the complexity of ocular conditions increases, the demand for combined ultrasound systems is expected to rise, reflecting the evolving needs of eye care professionals. Their multifunctionality makes them ideal for practices aiming to offer a complete range of diagnostic services.

Pachymetry Ultrasound:

Pachymetry ultrasound devices are specifically designed to measure the thickness of the cornea, a vital parameter in the assessment of glaucoma and other corneal diseases. Accurate corneal thickness measurements are essential for diagnosing and managing conditions such as keratoconus and for planning procedures like LASIK surgery. The growing awareness of the importance of corneal health in relation to overall eye care is driving the adoption of pachymetry ultrasound devices. As the focus on personalized eye care increases and more patients seek refractive surgeries, the demand for pachymetry ultrasound devices is expected to grow substantially, solidifying their place in ophthalmic diagnostics.

Ultrasound Biomicroscopy:

Ultrasound biomicroscopy (UBM) is a high-frequency ultrasound imaging technique that provides detailed images of the anterior segment of the eye, including the cornea, iris, and ciliary body. This advanced imaging modality is particularly valuable in diagnosing and monitoring conditions such as angle-closure glaucoma and intraocular tumors. UBM's ability to visualize fine anatomical details enhances its utility in clinical practice, making it a critical tool for ophthalmologists. The increasing prevalence of anterior segment diseases and the need for precise imaging for surgical planning are propelling the demand for UBM devices. As the technology continues to advance, the market for ultrasound biomicroscopy is poised for significant growth.

By Application

Retina and Vitreous:

The application of ophthalmic ultrasound devices for the retina and vitreous is crucial for diagnosing and managing various retinal diseases, including retinal tears, detachment, and other vitreoretinal disorders. The ability to visualize the posterior segment of the eye through ultrasound imaging is invaluable, particularly in cases where traditional examination methods are limited. The increasing incidence of retinal pathologies, driven by factors such as aging populations and rising diabetes prevalence, is fueling the demand for ultrasound devices tailored for retinal assessments. As more healthcare providers recognize the importance of early diagnosis and treatment of these conditions, the market for ultrasound devices in this application area is expected to expand significantly.

Cornea:

Ultrasound devices play a pivotal role in assessing corneal health, particularly in diagnosing conditions such as corneal edema, dystrophies, and keratoconus. The ability to measure corneal thickness and visualize its structure enhances clinical decision-making in the management of corneal diseases. With the increasing focus on corneal transplants and refractive surgeries, there is a growing demand for ultrasound devices specialized in corneal imaging. The continuous advancements in ultrasound technology, including high-resolution imaging capabilities, are improving diagnostic precision, thereby boosting the application of ultrasound devices for corneal assessments. As awareness around corneal health increases, more practitioners are likely to adopt these technologies.

Glaucoma:

Ultrasound devices are integral in the diagnosis and management of glaucoma, a leading cause of irreversible blindness worldwide. The ability to measure the optic nerve head and assess the anatomy of the anterior chamber is critical in glaucoma evaluations. With the rise in glaucoma screening initiatives and the aging population, the demand for ultrasound devices specifically designed for glaucoma assessments is on the rise. Furthermore, advancements in imaging technologies that enable detailed visualization of the optic nerve and surrounding structures are enhancing the diagnostic capabilities of ophthalmologists. As the healthcare landscape continues to evolve, the role of ultrasound in glaucoma management is expected to grow substantially.

Uveal Tumors:

The detection and management of uveal tumors, including melanoma and metastasis, significantly benefit from the use of ophthalmic ultrasound devices. These devices provide essential imaging capabilities that help in the characterization and monitoring of uveal tumors. With rising awareness of eye cancer and the need for timely intervention, the demand for ultrasound devices for this application is likely to increase. Additionally, technological advancements that allow enhanced imaging detail and accuracy are further driving this trend. As more practitioners recognize the importance of ultrasound in oncological assessments, the market for ophthalmic ultrasound devices in the uveal tumor segment is expected to expand.

Others:

In addition to the primary applications of ophthalmic ultrasound devices, there exist several other applications that warrant attention, including assessments related to ocular trauma, foreign body detection, and pre-operative evaluations for cataract surgeries. The flexibility of ultrasound technology allows it to adapt to various clinical scenarios, making it a valuable tool for ophthalmologists. As the understanding of ocular health evolves, the applications of ultrasound devices are likely to broaden, leading to increased adoption in diverse clinical settings. The versatility and effectiveness of ultrasound imaging in a range of applications will continue to foster growth in this segment of the market.

By End User

Hospitals:

Hospitals represent a significant end-user segment in the ophthalmic ultrasound devices market, driven by their comprehensive eye care services and advanced diagnostic capabilities. Hospital settings typically accommodate a larger patient population, necessitating the use of efficient and reliable diagnostic tools like ultrasound devices. The availability of multidisciplinary teams, including ophthalmologists, optometrists, and specialized nurses, enhances patient care and ensures that advanced imaging technologies are effectively utilized. Additionally, hospitals are increasingly investing in upgrading their diagnostic equipment to incorporate the latest ultrasound technologies, thus further propelling market growth. As hospitals expand their ophthalmic services to meet growing patient demand, the adoption of ultrasound devices is expected to increase progressively.

Ophthalmic Clinics:

Ophthalmic clinics are a key end-user segment in the market for ultrasound devices, as these facilities specialize in providing eye care services. The compact nature of ophthalmic clinics allows them to focus on tailored patient care, making the incorporation of advanced diagnostic tools essential. The growing trend of patients seeking specialized eye care has led to an increase in the establishment of ophthalmic clinics, thus driving demand for ultrasound devices. With the emphasis on early diagnosis and treatment in these settings, the need for accurate imaging technologies is paramount. The rising competition among clinics to offer advanced diagnostic services is also likely to contribute to the growth of ultrasound device adoption in this segment.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly becoming a prominent end-user segment in the ophthalmic ultrasound devices market. These centers focus on providing outpatient surgical services, including ophthalmic procedures, which require efficient and precise diagnostic tools. The growing trend of minimally invasive eye surgeries performed in ASCs has created a demand for advanced imaging technologies that can aid in pre-operative assessments and intraoperative guidance. The emphasis on patient comfort and quick recovery times in ASCs further drives the adoption of ultrasound devices, as they facilitate effective evaluations without the need for invasive procedures. As the popularity of ASCs continues to rise, so too will the utilization of ophthalmic ultrasound devices in these settings.

By Modality

Portable:

Portable ophthalmic ultrasound devices have gained significant traction in the market due to their convenience and ease of use. These devices allow healthcare professionals to conduct eye examinations at the point of care, making them especially valuable in emergency situations, rural settings, or for home healthcare applications. The portability of these devices ensures that they can be easily transported between different clinical environments, thus expanding their usability. Furthermore, advancements in technology have enabled the development of compact ultrasound systems without compromising image quality, facilitating their integration into various healthcare facilities. As the demand for accessible eye care increases, the market for portable ultrasound devices is expected to witness robust growth.

Standalone:

Standalone ophthalmic ultrasound devices are traditionally used in specialized clinical settings and hospitals to conduct thorough eye examinations. These devices are often equipped with advanced imaging capabilities and enhanced features that allow for detailed assessments of ocular structures. Their stationary nature means they provide high-quality imaging, but they require dedicated space within healthcare facilities. Standalone devices are typically favored for their comprehensive functionalities and advanced features, which cater to a wide range of ophthalmic applications. The consistent demand for high-resolution and precise imaging in established healthcare settings is likely to sustain the growth of the standalone ultrasound device segment.

By Region

The regional analysis of the ophthalmic ultrasound devices market indicates a significant presence in North America, which accounted for approximately 40% of the global market share in 2023. The region's dominance can be attributed to the well-established healthcare infrastructure, high prevalence of eye diseases, and the presence of key market players driving continuous innovation in ultrasound technology. Furthermore, the growing geriatric population and their susceptibility to ocular disorders are fueling demand for advanced diagnostic devices. North America is projected to witness a CAGR of around 6.5% during the forecast period, driven by increasing investments in healthcare and an ongoing shift towards preventive care.

Europe holds a notable position in the ophthalmic ultrasound devices market, capturing around 30% of the global share in 2023. The growth of this region is primarily driven by the increasing awareness of eye health and the rising prevalence of ocular diseases, which have prompted enhanced screening initiatives. Countries such as Germany, France, and the UK are leading the charge in adopting advanced ultrasound technologies, supported by robust healthcare systems. The Asia Pacific region is also experiencing a rapid expansion in the market, with projected growth rates surpassing 8.0% CAGR. This growth can be attributed to rising investment in healthcare infrastructure, increasing healthcare accessibility, and a growing awareness of eye care among the population. As emerging economies continue to improve their healthcare services, the demand for ophthalmic ultrasound devices is expected to rise significantly.

Opportunities

The ophthalmic ultrasound devices market presents numerous opportunities driven by advancements in technology and changes in healthcare delivery models. One significant opportunity lies in the increasing integration of artificial intelligence (AI) and machine learning into ultrasound imaging systems. These technologies can enhance diagnostic accuracy, streamline workflows, and reduce the time required for image interpretation. As AI continues to evolve, its incorporation into ophthalmic ultrasound devices may revolutionize the way eye care is delivered, leading to more personalized and efficient patient management. Additionally, the growing trend of telemedicine and remote patient monitoring opens up new avenues for the utilization of portable ultrasound devices, enabling comprehensive eye care even in remote locations. This shift towards virtual care can significantly increase the adoption of ophthalmic ultrasound devices and improve overall patient access to essential diagnostic services.

Furthermore, the increasing global focus on preventive healthcare is creating opportunities for the ophthalmic ultrasound devices market to flourish. With more healthcare systems prioritizing early detection and intervention for ocular diseases, the demand for advanced diagnostic tools that facilitate timely treatment will continue to rise. Additionally, the expansion of strategic partnerships between manufacturers and healthcare providers can lead to improved product offerings and greater market penetration. The growing emphasis on training and education for healthcare professionals in utilizing advanced ultrasound technologies also plays a vital role in maximizing the potential of ultrasound devices in ophthalmology. By enhancing awareness and expertise in ultrasound applications, the market can capitalize on these opportunities to drive overall growth.

Threats

Despite the promising growth trajectory of the ophthalmic ultrasound devices market, several threats could hinder its progress. One major concern is the presence of a competitive market landscape, characterized by numerous established players and new entrants vying for market share. This intense competition may lead to price wars, which can adversely affect profit margins for manufacturers. Additionally, the rapid pace of technological innovation necessitates continuous investment in research and development to keep up with market demands and stay ahead of the competitors. Failure to adapt to changing consumer preferences and technological advancements may result in obsolescence of existing products, further threatening the market position of various companies.

Another potential threat is the increasing scrutiny regarding the safety and efficacy of medical devices, including ophthalmic ultrasound systems. Regulatory bodies are tightening their approval processes, requiring manufacturers to invest more time and resources in compliance and quality assurance. Any delays in product approvals or adverse events associated with ultrasound devices may impact consumer trust and sales. Furthermore, economic uncertainties and budget constraints faced by healthcare systems could lead to reduced spending on advanced diagnostic technologies, limiting market growth. As these potential threats loom, stakeholders in the ophthalmic ultrasound devices market must navigate these challenges proactively to ensure sustained growth and innovation.

Competitor Outlook

• Alcon Laboratories, Inc.
• Bausch Health Companies Inc.
• Heidelberg Engineering GmbH
• Ellex Medical Lasers Limited
• Quantel Medical
• Optos Plc
• Nidek Co., Ltd.
• American Optical Corporation
• Canon Inc.
• Carestream Health, Inc.
• Reichert Technologies
• Samsung Medison Co., Ltd.
• Sonosite, Inc.
• Hitachi Medical Systems
• Hugo R. Ahrens GmbH

The competitive landscape of the ophthalmic ultrasound devices market is characterized by a mix of established global players, emerging companies, and a growing number of specialized manufacturers. The key players are continuously engaged in research and development activities to enhance their product portfolios, thereby addressing the evolving needs of ophthalmologists and healthcare providers. Collaboration and partnerships between manufacturers and hospitals or clinics are common strategies employed to expand market reach and improve product visibility. Furthermore, companies are increasingly focusing on technological advancements, such as integrating artificial intelligence and machine learning capabilities into their ultrasound devices, to gain a competitive edge and enhance diagnostic accuracy.

Some of the major companies in the ophthalmic ultrasound devices market include Alcon Laboratories, Inc. and Bausch Health Companies Inc., which are recognized for their extensive range of ophthalmic products and strong market presence. Alcon, a global leader in eye care, offers innovative ultrasound devices designed to deliver high-quality imaging and enhance surgical outcomes. Bausch Health, on the other hand, has a diverse portfolio that includes advanced imaging technologies aimed at improving patient diagnosis and treatment. Their commitment to research and innovation positions them favorably in the market, enabling them to cater to the growing demand for advanced ophthalmic solutions.

Moreover, Heidelberg Engineering GmbH is known for its cutting-edge imaging systems, including ultrasound devices that offer high-resolution imaging for detailed assessments of ocular conditions. Ellex Medical Lasers Limited focuses on developing technologies for diagnosing and treating eye diseases, including advanced ultrasound solutions tailored for specific clinical applications. The strong emphasis on improving patient outcomes and enhancing surgical precision through innovative technologies is a common theme among key players in the market. As the industry continues to evolve, these companies are likely to maintain their competitive advantage by leveraging their expertise and focusing on customer-centric advancements.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Optos Plc
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Canon Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Sonosite, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Nidek Co., Ltd.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Quantel Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Hugo R. Ahrens GmbH
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Reichert Technologies
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Carestream Health, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Hitachi Medical Systems
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Alcon Laboratories, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Samsung Medison Co., Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Heidelberg Engineering GmbH
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 American Optical Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Bausch Health Companies Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Ellex Medical Lasers Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Ophthalmic Ultrasound Devices Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Ophthalmic Clinics
    • 6.1.3 Ambulatory Surgical Centers
  • 6.2 Ophthalmic Ultrasound Devices Market, By Modality
    • 6.2.1 Portable
    • 6.2.2 Standalone
  • 6.3 Ophthalmic Ultrasound Devices Market, By Application
    • 6.3.1 Retina and Vitreous
    • 6.3.2 Cornea
    • 6.3.3 Glaucoma
    • 6.3.4 Uveal Tumors
    • 6.3.5 Others
  • 6.4 Ophthalmic Ultrasound Devices Market, By Product Type
    • 6.4.1 A-scan Ultrasound
    • 6.4.2 B-scan Ultrasound
    • 6.4.3 Combined A/B-scan Ultrasound
    • 6.4.4 Pachymetry Ultrasound
    • 6.4.5 Ultrasound Biomicroscopy

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Ophthalmic Ultrasound Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Ophthalmic Ultrasound Devices market is categorized based on

By Product Type

• A-scan Ultrasound
• B-scan Ultrasound
• Combined A/B-scan Ultrasound
• Pachymetry Ultrasound
• Ultrasound Biomicroscopy

By Application

• Retina and Vitreous
• Cornea
• Glaucoma
• Uveal Tumors
• Others

By End User

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers

By Modality

• Portable
• Standalone

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Alcon Laboratories, Inc.
• Bausch Health Companies Inc.
• Heidelberg Engineering GmbH
• Ellex Medical Lasers Limited
• Quantel Medical
• Optos Plc
• Nidek Co., Ltd.
• American Optical Corporation
• Canon Inc.
• Carestream Health, Inc.
• Reichert Technologies
• Samsung Medison Co., Ltd.
• Sonosite, Inc.
• Hitachi Medical Systems
• Hugo R. Ahrens GmbH